Last reviewed · How we verify

Thiapride — Competitive Intelligence Brief

Thiapride (TIAPRIDE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: tiapride. Area: Neuroscience.

discontinued tiapride D(4) dopamine receptor, Alpha-2A adrenergic receptor, D(2) dopamine receptor Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Thiapride (TIAPRIDE). Thiapride works by blocking the D(4) dopamine receptor, which helps to regulate mood and reduce symptoms of certain psychiatric conditions.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Thiapride TARGET TIAPRIDE discontinued tiapride D(4) dopamine receptor, Alpha-2A adrenergic receptor, D(2) dopamine receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (tiapride class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Thiapride — Competitive Intelligence Brief. https://druglandscape.com/ci/tiapride. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: